As shown in Supplementary Figure 1 (see Supplementary Digital Content 2, http://links.lww.com/CTG/A771), anti-MAA autoantibody levels were significantly increased in IBD compared with non-IBD gastrointestinal diseases (P = 0.0074). This evidence concerns the gene NAA10 and irritable bowel syndrome.